This chapter focuses on the recent advances in biotechnological innovations in the fields of genetics and molecular biology and their beneficial effects in the health care, pharmaceutical and agricultural industries. The negative and positive effects of intellectual property rights, particularly...

This book contains 22 chapters focusing on the emerging legal, social and regulatory issues pertaining to biotechnology and intellectual property rights (IPRs) in agriculture, food, pharmaceutics, health care and industry. Expert opinions are also presented by premier academicians, scientists and...

This chapter defines biosimilars/biogenerics and discusses the importance of biotherapeutics in healthcare. The intellectual property rights issues, the resolution of patent disputes, new intellectual property challenges, regulatory issues and guidelines are discussed. The nomenclature of...

This chapter discusses public interest and the patent system in healthcare innovations. The association between patents and commercial biomedicine, the actual claims of drug companies and what the patent law permits, and the patenting of enantiomers and other variants are described.